Work

Efficacy and safety of selinexor in recurrent glioblastoma.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.2005

Authors: Andrew B. Lassman, Patrick Y. Wen, Martin J. Van Den Bent, Scott Randall Plotkin, Anna Maria Elisabeth Walenkamp, Xiu Huang, Karla Rodriguez-Lopez, Michael G. Kauffman, Sharon Shacham, Morten Mau-Sørensen

Institutions: Columbia University Irving Medical Center, Harvard University, Dana-Farber Brigham Cancer Center, Erasmus MC, Erasmus MC Cancer Institute, Massachusetts General Hospital, University Medical Center Groningen, University of Groningen, Karyopharm Therapeutics (United States), Rigshospitalet

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947445708

Cites:

Cited by: 8

Related to: 10